Val­neva's chikun­gun­ya vac­cine on track for FDA nod af­ter long-term an­ti­body da­ta

The chikun­gun­ya virus met its match in Val­ne­va’s vac­cine can­di­date, VLA1553, ac­cord­ing to da­ta from an an­ti­body per­sis­tence tri­al re­leased to­day.

The tri­al found that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER